chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: 2nd dose COVID vaccine given 1 week early. During 15 minute observation period, pt. did not have any signs/symptoms of adverse effects and left clinic after observation.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was 17 y.o. when receiving Moderna.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Pain in extremity
Clinical narrative: Patient was given 0.5ml for booster (3rd dosage) instead of 0.25ml, no symptoms of adverse reaction experienced by patient. Called and spoke with patient on 1/18/2022 and patient states just soreness on arm same as the first 2 dosage and letter sent to patient also.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was administered the Moderna Covid-19 Vaccine at age 17 in error, not approved for under 18. Patient had NO adverse outcomes, this is a report of a medication error.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Mental status changes, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: hospitalized with mental status changes with a breakthrough COVID 19 infection
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Discomfort
Clinical narrative: Pain in armpit of vaccinated arm. Advised using OTC for discomfort and to follow-up in 3 days sooner if symptoms worsen or new symptoms develop.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Headache, Injection site erythema, Lymphadenopathy
Clinical narrative: severe headache, red line at the site of the injection going to the underarm, swelling of lymph nodes on left side of body ( under arm, clavidle). severe pain under arm. these symptoms are still present 3 days later and not any better.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Head discomfort, Magnetic resonance imaging, Tinnitus, Ultrasound scan
Clinical narrative: I feel very bad I have pulsatile tinnitus and pressure in my head I have been like this for 7 months.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: 2nd dose COVID vaccine given 1 week early. During 15 minute observation period, pt. did not have any signs/symptoms of adverse effects and left clinic after observation.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Patient had rash on abdomen, back, arm, neck.  Administered Benedryl 12/5mh / 5 mL at 9:02 am.  Continued to monitor for 30 minutes, but rash continued to progress, so patient was walked to the ED at 9:22 am.  The ED observed him.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest pain, Chills, Condition aggravated, Eructation
Clinical narrative: Within few hours I had severe chills/body aches/headache which then also lead to a fever, unable to eat & major migraine. All of which lasted for 4 days except for the migraine. The migraine reduced to a lower grade/bad headache which lasted an additional 5 days. I am still unable to eat normal meals, certain foods, etc. I instantly become nauseous, get pains in my stomach, belching and chest pains.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Headache, Migraine, Nausea, Pain
Clinical narrative: Within few hours I had severe chills/body aches/headache which then also lead to a fever, unable to eat & major migraine. All of which lasted for 4 days except for the migraine. The migraine reduced to a lower grade/bad headache which lasted an additional 5 days. I am still unable to eat normal meals, certain foods, etc. I instantly become nauseous, get pains in my stomach, belching and chest pains.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Within few hours I had severe chills/body aches/headache which then also lead to a fever, unable to eat & major migraine. All of which lasted for 4 days except for the migraine. The migraine reduced to a lower grade/bad headache which lasted an additional 5 days. I am still unable to eat normal meals, certain foods, etc. I instantly become nauseous, get pains in my stomach, belching and chest pains.
Age: 12.0
Sex: F
Vaccine: UNK
Symptoms: Anxiety, Heart rate increased, Myalgia
Clinical narrative: Patient seen in the office today.  She reported having COVID 19 booster on 1/21/22.  On 01/23/22 she is having episodes of rapid heart rate that last a few minutes to more than an hour.  These episodes make her anxious.  She is also complaining of generalized muscle aches.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine kept in freezer for greater than 14 days.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was given Moderna Covid-19 Vaccine at age 17 in error, not approved for under 18. Patient had NO adverse outcome, this is a report of a medication error.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Postmenopausal haemorrhage
Clinical narrative: Patient has been post-menapausal for 3 years.  One day after receiving the Moderna COVID vaccine, she started menstrual bleeding which lasted about 24 hours.
Age: 44.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrophy, Injection site pain, Pain, Pain in extremity, Rotator cuff syndrome
Clinical narrative: Left arm has intrusive pain, always when lifting above a certain point similar to impingement, however the pain is in the muscle and radiates from the injection site rather than "inside the joint" like a tendon impingement would.  It also has shooting pain sometimes just using it normally, not when raising above the always-painful point (randomly depending on which muscle groups are in use, gripping and moving things around with shoulder joint in resting position, which does not seem like the joint but the muscles).  It has full mobility assuming I ignore the intense pain, also suggesting it's not a simple impingement, and nothing "pops" ever.  In the few months I was hoping it would just go away, the arm shows some visible atrophy (beyond the normal difference of it being my non-dominant side) likely from avoidance of using it.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: hospitalized with a breakthrough COVID 19 infection
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Biopsy, COVID-19, Coagulopathy, Diarrhoea
Clinical narrative: COVID Vaccine Breakthrough Case Pfizer Dose 1 9/23/21 (EW0177) COVID Positive 10/6/21  10/6/21: 62-year-old lady presented to the emergency room with episode of coffee-ground emesis.  Patient reported some abdominal cramping and that was followed up with vomiting that turned to be coffee- ground.  Apparently, she had nonbloody diarrhea yesterday. She denies fever. She has a history of mitral valve replacement and does take warfarin.  The INR was noted to be greater than 9 this morning.  10/8/21: 62-year-old lady presented to the emergency room with history of hematemesis.  Patient was noted to have an INR that was 9. Coagulopathy was reversed with vitamin K and FFP, and the patient underwent EGD.  EGD reported that the patient has a gastric inflammation and a biopsy was taken.  The patient had another episode of vomiting. __________ any evidence of bleeding.  The patient feels better.  She denies cough.  She denies shortness of breath.  She is back to her baseline. Her hemoglobin has been stable.  She will be discharged home on Lovenox bridging to Coumadin until her INR is at least at 2.5.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Gastritis, Haematemesis, Haemoglobin normal, International normalised ratio increased, Oesophagogastroduodenoscopy abnormal
Clinical narrative: COVID Vaccine Breakthrough Case Pfizer Dose 1 9/23/21 (EW0177) COVID Positive 10/6/21  10/6/21: 62-year-old lady presented to the emergency room with episode of coffee-ground emesis.  Patient reported some abdominal cramping and that was followed up with vomiting that turned to be coffee- ground.  Apparently, she had nonbloody diarrhea yesterday. She denies fever. She has a history of mitral valve replacement and does take warfarin.  The INR was noted to be greater than 9 this morning.  10/8/21: 62-year-old lady presented to the emergency room with history of hematemesis.  Patient was noted to have an INR that was 9. Coagulopathy was reversed with vitamin K and FFP, and the patient underwent EGD.  EGD reported that the patient has a gastric inflammation and a biopsy was taken.  The patient had another episode of vomiting. __________ any evidence of bleeding.  The patient feels better.  She denies cough.  She denies shortness of breath.  She is back to her baseline. Her hemoglobin has been stable.  She will be discharged home on Lovenox bridging to Coumadin until her INR is at least at 2.5.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection, Vomiting
Clinical narrative: COVID Vaccine Breakthrough Case Pfizer Dose 1 9/23/21 (EW0177) COVID Positive 10/6/21  10/6/21: 62-year-old lady presented to the emergency room with episode of coffee-ground emesis.  Patient reported some abdominal cramping and that was followed up with vomiting that turned to be coffee- ground.  Apparently, she had nonbloody diarrhea yesterday. She denies fever. She has a history of mitral valve replacement and does take warfarin.  The INR was noted to be greater than 9 this morning.  10/8/21: 62-year-old lady presented to the emergency room with history of hematemesis.  Patient was noted to have an INR that was 9. Coagulopathy was reversed with vitamin K and FFP, and the patient underwent EGD.  EGD reported that the patient has a gastric inflammation and a biopsy was taken.  The patient had another episode of vomiting. __________ any evidence of bleeding.  The patient feels better.  She denies cough.  She denies shortness of breath.  She is back to her baseline. Her hemoglobin has been stable.  She will be discharged home on Lovenox bridging to Coumadin until her INR is at least at 2.5.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: patient received multiple of booster shot dose of vaccine which is against protocol
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Lip swelling, Swelling face
Clinical narrative: vaccine 1/21/22. face and lips swelling 1/23/22 (>48 hours after vaccination). visited aprn 1/24/22 and received steroid shot and benadryl.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness unilateral, Tinnitus
Clinical narrative: Ringing in Left ear, Loss of hearing in Left ear
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pain in extremity, Palpitations
Clinical narrative: Heart palpitations, profuse myalgia pain, chills, severe headache 1/24/22 myalgia pain in both arms.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Atrial fibrillation, Blood bicarbonate normal, Blood glucose normal, Blood lactic acid
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/8/21 (ER8737) Pfizer Dose 2 4/30/21 (ER8734) COVID Positive 9/18/21  9/17/21: -Patient is an 85 yo female with medical history of  moderate persistent asthma , atrial fibrillation on coumadin, moderate aortic stenosis  , HTN , GERD , CVA, HLD , Hyponatremia, Left thyroid nodule.  -History obtained from patient's son who is at bedside.  -She is presenting with worsening shortness of breath and wheezing. She was found to be COVID positive in the ER.  -Her symptoms started 2 days ago but got worse today afternoon.Symptoms not responding to her home inhalers and nebulizers.  -She was being managed with PO steroids as outpatient without improvement in symptoms. She follows Dr ( pulmonology) as outpatient.  -She has been vaccinated for COVID. Recieved both doses of pfizer vaccine in April  -Her vitals were significant for tachycardia 110-120s,RR 20s,  no fever, BP 135/79, saturating 93% on room air. Per ER provider she was noted to be wheezing  -CXR showed focal airspace disease at the right lung base probably representing pneumonia and 2 cm nodular density at the right apex.  Developing pulmonary nodule needs to be excluded.  Recommend the nonemergent chest CT.  -Labwork remarkable for normal wbc ,  hyponatremia 125 ( unclear baseline but has a history of hyponatremia), glucose 155, ABG ( PH 7.48, pCO2 36, pO2 91, HCO3 27), lactate 2.2 , INR 5, rapid COVID positive  -She received Duoneb , IV Ceftriaxone/Azithromycin , IV solumedrol , 1L NS with improvement in her symptoms  -ER provider concerned she may progress and needs inpatient monitoring because she is still tachycardic and tachypnoiec despite not requiring supplemental oxygen. She will also need management for her asthma/COPD exacerbation which is triggered by COVID .  10/10/21: 86-year-old woman who presented with 2 days history of shortness of breath and wheezing.  COVID-19 PCR was subsequently positive, chest x-ray demonstrated right basilar infiltrate.  She was admitted for treatment of COVID-19 pneumonia with steroids and broad-spectrum empiric antibiotic therapy.  However she went into atrial fibrillation rapid ventricular response, developed worsening hypoxia and infiltrates requiring transfer to the intensive care unit.  She required prolonged supplemental oxygen therapy via BiPAP and OptiFlow.  She was gradually weaned off supplemental oxygen, has been stable on room air for the last few days.  She is physically deconditioned however patient's family have declined skilled placement and have opted to take her home with the support of home health services.  She has been discharged in fair medical condition.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pH increased, Blood sodium decreased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/8/21 (ER8737) Pfizer Dose 2 4/30/21 (ER8734) COVID Positive 9/18/21  9/17/21: -Patient is an 85 yo female with medical history of  moderate persistent asthma , atrial fibrillation on coumadin, moderate aortic stenosis  , HTN , GERD , CVA, HLD , Hyponatremia, Left thyroid nodule.  -History obtained from patient's son who is at bedside.  -She is presenting with worsening shortness of breath and wheezing. She was found to be COVID positive in the ER.  -Her symptoms started 2 days ago but got worse today afternoon.Symptoms not responding to her home inhalers and nebulizers.  -She was being managed with PO steroids as outpatient without improvement in symptoms. She follows Dr ( pulmonology) as outpatient.  -She has been vaccinated for COVID. Recieved both doses of pfizer vaccine in April  -Her vitals were significant for tachycardia 110-120s,RR 20s,  no fever, BP 135/79, saturating 93% on room air. Per ER provider she was noted to be wheezing  -CXR showed focal airspace disease at the right lung base probably representing pneumonia and 2 cm nodular density at the right apex.  Developing pulmonary nodule needs to be excluded.  Recommend the nonemergent chest CT.  -Labwork remarkable for normal wbc ,  hyponatremia 125 ( unclear baseline but has a history of hyponatremia), glucose 155, ABG ( PH 7.48, pCO2 36, pO2 91, HCO3 27), lactate 2.2 , INR 5, rapid COVID positive  -She received Duoneb , IV Ceftriaxone/Azithromycin , IV solumedrol , 1L NS with improvement in her symptoms  -ER provider concerned she may progress and needs inpatient monitoring because she is still tachycardic and tachypnoiec despite not requiring supplemental oxygen. She will also need management for her asthma/COPD exacerbation which is triggered by COVID .  10/10/21: 86-year-old woman who presented with 2 days history of shortness of breath and wheezing.  COVID-19 PCR was subsequently positive, chest x-ray demonstrated right basilar infiltrate.  She was admitted for treatment of COVID-19 pneumonia with steroids and broad-spectrum empiric antibiotic therapy.  However she went into atrial fibrillation rapid ventricular response, developed worsening hypoxia and infiltrates requiring transfer to the intensive care unit.  She required prolonged supplemental oxygen therapy via BiPAP and OptiFlow.  She was gradually weaned off supplemental oxygen, has been stable on room air for the last few days.  She is physically deconditioned however patient's family have declined skilled placement and have opted to take her home with the support of home health services.  She has been discharged in fair medical condition.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea, Hyponatraemia, Hypoxia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/8/21 (ER8737) Pfizer Dose 2 4/30/21 (ER8734) COVID Positive 9/18/21  9/17/21: -Patient is an 85 yo female with medical history of  moderate persistent asthma , atrial fibrillation on coumadin, moderate aortic stenosis  , HTN , GERD , CVA, HLD , Hyponatremia, Left thyroid nodule.  -History obtained from patient's son who is at bedside.  -She is presenting with worsening shortness of breath and wheezing. She was found to be COVID positive in the ER.  -Her symptoms started 2 days ago but got worse today afternoon.Symptoms not responding to her home inhalers and nebulizers.  -She was being managed with PO steroids as outpatient without improvement in symptoms. She follows Dr ( pulmonology) as outpatient.  -She has been vaccinated for COVID. Recieved both doses of pfizer vaccine in April  -Her vitals were significant for tachycardia 110-120s,RR 20s,  no fever, BP 135/79, saturating 93% on room air. Per ER provider she was noted to be wheezing  -CXR showed focal airspace disease at the right lung base probably representing pneumonia and 2 cm nodular density at the right apex.  Developing pulmonary nodule needs to be excluded.  Recommend the nonemergent chest CT.  -Labwork remarkable for normal wbc ,  hyponatremia 125 ( unclear baseline but has a history of hyponatremia), glucose 155, ABG ( PH 7.48, pCO2 36, pO2 91, HCO3 27), lactate 2.2 , INR 5, rapid COVID positive  -She received Duoneb , IV Ceftriaxone/Azithromycin , IV solumedrol , 1L NS with improvement in her symptoms  -ER provider concerned she may progress and needs inpatient monitoring because she is still tachycardic and tachypnoiec despite not requiring supplemental oxygen. She will also need management for her asthma/COPD exacerbation which is triggered by COVID .  10/10/21: 86-year-old woman who presented with 2 days history of shortness of breath and wheezing.  COVID-19 PCR was subsequently positive, chest x-ray demonstrated right basilar infiltrate.  She was admitted for treatment of COVID-19 pneumonia with steroids and broad-spectrum empiric antibiotic therapy.  However she went into atrial fibrillation rapid ventricular response, developed worsening hypoxia and infiltrates requiring transfer to the intensive care unit.  She required prolonged supplemental oxygen therapy via BiPAP and OptiFlow.  She was gradually weaned off supplemental oxygen, has been stable on room air for the last few days.  She is physically deconditioned however patient's family have declined skilled placement and have opted to take her home with the support of home health services.  She has been discharged in fair medical condition.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, International normalised ratio increased, Lung disorder, Lung infiltration, PCO2 normal
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/8/21 (ER8737) Pfizer Dose 2 4/30/21 (ER8734) COVID Positive 9/18/21  9/17/21: -Patient is an 85 yo female with medical history of  moderate persistent asthma , atrial fibrillation on coumadin, moderate aortic stenosis  , HTN , GERD , CVA, HLD , Hyponatremia, Left thyroid nodule.  -History obtained from patient's son who is at bedside.  -She is presenting with worsening shortness of breath and wheezing. She was found to be COVID positive in the ER.  -Her symptoms started 2 days ago but got worse today afternoon.Symptoms not responding to her home inhalers and nebulizers.  -She was being managed with PO steroids as outpatient without improvement in symptoms. She follows Dr ( pulmonology) as outpatient.  -She has been vaccinated for COVID. Recieved both doses of pfizer vaccine in April  -Her vitals were significant for tachycardia 110-120s,RR 20s,  no fever, BP 135/79, saturating 93% on room air. Per ER provider she was noted to be wheezing  -CXR showed focal airspace disease at the right lung base probably representing pneumonia and 2 cm nodular density at the right apex.  Developing pulmonary nodule needs to be excluded.  Recommend the nonemergent chest CT.  -Labwork remarkable for normal wbc ,  hyponatremia 125 ( unclear baseline but has a history of hyponatremia), glucose 155, ABG ( PH 7.48, pCO2 36, pO2 91, HCO3 27), lactate 2.2 , INR 5, rapid COVID positive  -She received Duoneb , IV Ceftriaxone/Azithromycin , IV solumedrol , 1L NS with improvement in her symptoms  -ER provider concerned she may progress and needs inpatient monitoring because she is still tachycardic and tachypnoiec despite not requiring supplemental oxygen. She will also need management for her asthma/COPD exacerbation which is triggered by COVID .  10/10/21: 86-year-old woman who presented with 2 days history of shortness of breath and wheezing.  COVID-19 PCR was subsequently positive, chest x-ray demonstrated right basilar infiltrate.  She was admitted for treatment of COVID-19 pneumonia with steroids and broad-spectrum empiric antibiotic therapy.  However she went into atrial fibrillation rapid ventricular response, developed worsening hypoxia and infiltrates requiring transfer to the intensive care unit.  She required prolonged supplemental oxygen therapy via BiPAP and OptiFlow.  She was gradually weaned off supplemental oxygen, has been stable on room air for the last few days.  She is physically deconditioned however patient's family have declined skilled placement and have opted to take her home with the support of home health services.  She has been discharged in fair medical condition.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: PO2 normal, Physical deconditioning, Positive airway pressure therapy, SARS-CoV-2 test positive, Tachycardia
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/8/21 (ER8737) Pfizer Dose 2 4/30/21 (ER8734) COVID Positive 9/18/21  9/17/21: -Patient is an 85 yo female with medical history of  moderate persistent asthma , atrial fibrillation on coumadin, moderate aortic stenosis  , HTN , GERD , CVA, HLD , Hyponatremia, Left thyroid nodule.  -History obtained from patient's son who is at bedside.  -She is presenting with worsening shortness of breath and wheezing. She was found to be COVID positive in the ER.  -Her symptoms started 2 days ago but got worse today afternoon.Symptoms not responding to her home inhalers and nebulizers.  -She was being managed with PO steroids as outpatient without improvement in symptoms. She follows Dr ( pulmonology) as outpatient.  -She has been vaccinated for COVID. Recieved both doses of pfizer vaccine in April  -Her vitals were significant for tachycardia 110-120s,RR 20s,  no fever, BP 135/79, saturating 93% on room air. Per ER provider she was noted to be wheezing  -CXR showed focal airspace disease at the right lung base probably representing pneumonia and 2 cm nodular density at the right apex.  Developing pulmonary nodule needs to be excluded.  Recommend the nonemergent chest CT.  -Labwork remarkable for normal wbc ,  hyponatremia 125 ( unclear baseline but has a history of hyponatremia), glucose 155, ABG ( PH 7.48, pCO2 36, pO2 91, HCO3 27), lactate 2.2 , INR 5, rapid COVID positive  -She received Duoneb , IV Ceftriaxone/Azithromycin , IV solumedrol , 1L NS with improvement in her symptoms  -ER provider concerned she may progress and needs inpatient monitoring because she is still tachycardic and tachypnoiec despite not requiring supplemental oxygen. She will also need management for her asthma/COPD exacerbation which is triggered by COVID .  10/10/21: 86-year-old woman who presented with 2 days history of shortness of breath and wheezing.  COVID-19 PCR was subsequently positive, chest x-ray demonstrated right basilar infiltrate.  She was admitted for treatment of COVID-19 pneumonia with steroids and broad-spectrum empiric antibiotic therapy.  However she went into atrial fibrillation rapid ventricular response, developed worsening hypoxia and infiltrates requiring transfer to the intensive care unit.  She required prolonged supplemental oxygen therapy via BiPAP and OptiFlow.  She was gradually weaned off supplemental oxygen, has been stable on room air for the last few days.  She is physically deconditioned however patient's family have declined skilled placement and have opted to take her home with the support of home health services.  She has been discharged in fair medical condition.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Tachypnoea, Vaccine breakthrough infection, Wheezing, White blood cell count normal
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/8/21 (ER8737) Pfizer Dose 2 4/30/21 (ER8734) COVID Positive 9/18/21  9/17/21: -Patient is an 85 yo female with medical history of  moderate persistent asthma , atrial fibrillation on coumadin, moderate aortic stenosis  , HTN , GERD , CVA, HLD , Hyponatremia, Left thyroid nodule.  -History obtained from patient's son who is at bedside.  -She is presenting with worsening shortness of breath and wheezing. She was found to be COVID positive in the ER.  -Her symptoms started 2 days ago but got worse today afternoon.Symptoms not responding to her home inhalers and nebulizers.  -She was being managed with PO steroids as outpatient without improvement in symptoms. She follows Dr ( pulmonology) as outpatient.  -She has been vaccinated for COVID. Recieved both doses of pfizer vaccine in April  -Her vitals were significant for tachycardia 110-120s,RR 20s,  no fever, BP 135/79, saturating 93% on room air. Per ER provider she was noted to be wheezing  -CXR showed focal airspace disease at the right lung base probably representing pneumonia and 2 cm nodular density at the right apex.  Developing pulmonary nodule needs to be excluded.  Recommend the nonemergent chest CT.  -Labwork remarkable for normal wbc ,  hyponatremia 125 ( unclear baseline but has a history of hyponatremia), glucose 155, ABG ( PH 7.48, pCO2 36, pO2 91, HCO3 27), lactate 2.2 , INR 5, rapid COVID positive  -She received Duoneb , IV Ceftriaxone/Azithromycin , IV solumedrol , 1L NS with improvement in her symptoms  -ER provider concerned she may progress and needs inpatient monitoring because she is still tachycardic and tachypnoiec despite not requiring supplemental oxygen. She will also need management for her asthma/COPD exacerbation which is triggered by COVID .  10/10/21: 86-year-old woman who presented with 2 days history of shortness of breath and wheezing.  COVID-19 PCR was subsequently positive, chest x-ray demonstrated right basilar infiltrate.  She was admitted for treatment of COVID-19 pneumonia with steroids and broad-spectrum empiric antibiotic therapy.  However she went into atrial fibrillation rapid ventricular response, developed worsening hypoxia and infiltrates requiring transfer to the intensive care unit.  She required prolonged supplemental oxygen therapy via BiPAP and OptiFlow.  She was gradually weaned off supplemental oxygen, has been stable on room air for the last few days.  She is physically deconditioned however patient's family have declined skilled placement and have opted to take her home with the support of home health services.  She has been discharged in fair medical condition.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine left in freezer for greater than 14 days
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was given Moderna Covid-19 vaccine at age 17 on 9/10/21, not approved for under 18. Decision made by clinical team to complete the moderna series rather than switching in the middle of the initial series of immunizations. This represents that chose dose. Patient had NO adverse outcome, this is a report of a medication variance.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Fatigue, Injection site pain, Injection site reaction
Clinical narrative: *injection site pain and stiffness *persistent headache *muscle and joint pain and stiffness *(3) hours of chills and shivering that started 10 hours after injection *fatigue -all symptoms resolved 36 hours after injection
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Joint stiffness, Musculoskeletal stiffness
Clinical narrative: *injection site pain and stiffness *persistent headache *muscle and joint pain and stiffness *(3) hours of chills and shivering that started 10 hours after injection *fatigue -all symptoms resolved 36 hours after injection
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chronic obstructive pulmonary disease, Diarrhoea, Drug dependence, Gastritis viral
Clinical narrative: DISCHARGE DIAGNOSES:  1. Covid 19 w/ symptoms of nausea, vomiting and diarrhea 2. Tobacco abuse 3. COPD - stable 4. Opioid dependency on Methadone program   HOSPITAL COURSE: ASSESSMENT & PLAN: 56-year-old woman with history notable for opiate dependence, now presents with nausea vomiting and diarrhea, initially thought likely consistent with gastroenteritis, but in turn it is related to Covid 19 and these were her initial symptoms.    Below is her plan of care she rec'd while hospitalized:   Gastroenteritis with N/V likely related to COVID-19: Patient presented with complaint of vomiting and diarrhea since 12 PM on 1/14/2022 Patient is on the methadone program and did not pick up her dose on 1/14/2022  Concerning foodborne source could have been a chicken salad sandwich she ate earlier that day Overall vital signs and labs are stable Viral gastritis versus withdrawal from missing dose of methadone or dx of COVID positive She has not been on any of antibiotics to consider C. Difficile Is not on oxygen so does not require steroids or qualify for toci/bari Plan:  o If has more diarrhea we will check for enteric pathogens - she has not had any further diarrhea o Advised to eat a bland type diet o Given paperwork on proning and Incentive spirometer to exercise your lung, do every hour x t0 rep o Antitussives, and mucolytic's as needed -these are over the counter o Frequent positional changes, ambulate and up in chair for all meals o Full barrier protection - quarenting for 10 days - till 1/23/2022   History of opioid dependence: On methadone program  Pharmacy validated and noted she did not pick up her "take out" dose on 1/14/2022 Plan:  o Resume outpatient methadone 150 mg daily   History of COPD: Patient is/was a 1/2 pk day smoker for years.  Continue w/ PTA albuterol inhaler and nebulizer as needed, Spiriva 2.5 mcg actuation inhaler 2 puffs daily Encouraged tobacco cessation especially now w/ Covid
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Gastroenteritis, Nausea, SARS-CoV-2 test negative, Tobacco abuse, Vomiting
Clinical narrative: DISCHARGE DIAGNOSES:  1. Covid 19 w/ symptoms of nausea, vomiting and diarrhea 2. Tobacco abuse 3. COPD - stable 4. Opioid dependency on Methadone program   HOSPITAL COURSE: ASSESSMENT & PLAN: 56-year-old woman with history notable for opiate dependence, now presents with nausea vomiting and diarrhea, initially thought likely consistent with gastroenteritis, but in turn it is related to Covid 19 and these were her initial symptoms.    Below is her plan of care she rec'd while hospitalized:   Gastroenteritis with N/V likely related to COVID-19: Patient presented with complaint of vomiting and diarrhea since 12 PM on 1/14/2022 Patient is on the methadone program and did not pick up her dose on 1/14/2022  Concerning foodborne source could have been a chicken salad sandwich she ate earlier that day Overall vital signs and labs are stable Viral gastritis versus withdrawal from missing dose of methadone or dx of COVID positive She has not been on any of antibiotics to consider C. Difficile Is not on oxygen so does not require steroids or qualify for toci/bari Plan:  o If has more diarrhea we will check for enteric pathogens - she has not had any further diarrhea o Advised to eat a bland type diet o Given paperwork on proning and Incentive spirometer to exercise your lung, do every hour x t0 rep o Antitussives, and mucolytic's as needed -these are over the counter o Frequent positional changes, ambulate and up in chair for all meals o Full barrier protection - quarenting for 10 days - till 1/23/2022   History of opioid dependence: On methadone program  Pharmacy validated and noted she did not pick up her "take out" dose on 1/14/2022 Plan:  o Resume outpatient methadone 150 mg daily   History of COPD: Patient is/was a 1/2 pk day smoker for years.  Continue w/ PTA albuterol inhaler and nebulizer as needed, Spiriva 2.5 mcg actuation inhaler 2 puffs daily Encouraged tobacco cessation especially now w/ Covid
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE ADMINISTERED WAS STORED AT FREEZER TEMPERATURE FOR TOO LONG.  PATIENT IS BEING REVACCINATED.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Swollen tongue
Clinical narrative: PT EXPERIENCED SWALLOWEN FEET AND TONGUE THE NEXT MORNING. UNCONTROLLABLE ITCHING ALL OVER THE BODY.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Cough
Clinical narrative: Patient is fully vaccinated.  72-year-old male patient presents to the ED with COVID after having shortness of breath, cough, and myalgias for the past 3-4 days.He tested positive at Urgent Care earlier this morning.  The patient pulse ox on presentation was 90% on room air.  The patient denies any nausea, vomiting, diarrhea, abdominal pain, chest pain, fever, or chills at this time. DX acute renal insufficiency.  Pneumonia due to COVID 19.  CXR  Patchy bibasilar infiltrates consistent with COVID 19 pneumonia.   D-Dimer 464. Treatment:  Oxygen, decadron, vit D, remdesivir, Lovenox.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fibrin D dimer increased, Lung infiltration, Myalgia, SARS-CoV-2 test positive
Clinical narrative: Patient is fully vaccinated.  72-year-old male patient presents to the ED with COVID after having shortness of breath, cough, and myalgias for the past 3-4 days.He tested positive at Urgent Care earlier this morning.  The patient pulse ox on presentation was 90% on room air.  The patient denies any nausea, vomiting, diarrhea, abdominal pain, chest pain, fever, or chills at this time. DX acute renal insufficiency.  Pneumonia due to COVID 19.  CXR  Patchy bibasilar infiltrates consistent with COVID 19 pneumonia.   D-Dimer 464. Treatment:  Oxygen, decadron, vit D, remdesivir, Lovenox.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Pain, Sleep disorder
Clinical narrative: Chest pains, felt like a heart attack.  Severe chills and aches that woke me up.  I am a VERY deep sleeper.  I will sleep until 10AM if allowed and I have 4 kids.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given 0.5mg of Moderna vaccine instead of 0.25mg, there was no adverse reaction per patient, patient was called and also a letter was sent.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster dose given 3 months too early. Patient received second COVID-19 shot in November, and  given booster in January.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Vaccination site induration, Vaccination site reaction, Vaccination site warmth
Clinical narrative: erythematous rash to upper arm below vaccine site, warm, indurated, not circumerfential, appeared within 24 hrs of vaccine, now improving day 3
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Condition aggravated, Parkinson's disease
Clinical narrative: Complications of Parkinson's disease secondary to COVID-19.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, COVID-19 pneumonia, Chills, Death, Dehydration
Clinical narrative: Fever, chills, congestion, pneumonia, dehydration, stomach pain, death. #21-n (Hospitalization 11 days, remdesivir, oxygen, steroids, Patient died from COVID pneumonia on 1/6/22
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Pyrexia, Respiratory tract congestion
Clinical narrative: Fever, chills, congestion, pneumonia, dehydration, stomach pain, death. #21-n (Hospitalization 11 days, remdesivir, oxygen, steroids, Patient died from COVID pneumonia on 1/6/22
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Pt received 0.3 ml of the Pediatric formulation, and therefore was under-dosed.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: A 68-year-old female presented to ED with complaints of headache, body aches, congestion and  shortness of breath. Patient reported history of breast cancer and currently on chemo. Patient has fatigue and had a slight cough. Patient stated her biggest issue is her headache. Her head is pounding, she feels weak and fatigued. These symptoms started shortly after getting the COVID-19 booster on 1/18/2022.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Respiratory tract congestion
Clinical narrative: A 68-year-old female presented to ED with complaints of headache, body aches, congestion and  shortness of breath. Patient reported history of breast cancer and currently on chemo. Patient has fatigue and had a slight cough. Patient stated her biggest issue is her headache. Her head is pounding, she feels weak and fatigued. These symptoms started shortly after getting the COVID-19 booster on 1/18/2022.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Nasal congestion
Clinical narrative: I had fatigue and fever for 5 days. I had chest and nasal congestive, coughing, headache, body aches, and sore throat.  I am past the 14 day, I still have the congestive, fatigue and cough.  I went on Jan 8th, and was tested positive for Covid-19.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had fatigue and fever for 5 days. I had chest and nasal congestive, coughing, headache, body aches, and sore throat.  I am past the 14 day, I still have the congestive, fatigue and cough.  I went on Jan 8th, and was tested positive for Covid-19.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: On date of second dose, it was discovered that Moderna had been given as the first dose. Patient did not meet the minimum age of 18 years old. No signs or symptoms of adverse effects were noted.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Loss of consciousness
Clinical narrative: Light headed, Weak, Loss of consciousness
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine stored in freezer for greater than 14 days
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Agoraphobia, Muscular weakness, Phonophobia, Vision blurred
Clinical narrative: vision blurred, phonophobia, agoraphobia, muscular weakness
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Gram stain negative, Herpes simplex test negative, Pain, Vulval ulceration
Clinical narrative: Patient developed a Lipschulz ulcer after her 2nd dose of Pfizer covid vaccine in June 2021. She received her booster shot on 01/19/2022 and developed another Lipschulz ulcer 2 days later. The ulcer is very painful and is being treated with NSAID, & sitz bath.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Booster dose given early
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Nausea
Clinical narrative: swollen lymphnodes, shoulder pain, naseau
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Pt was given 0.3 ml of the Pediatric formulation, and therefor was under-dosed by 50%
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Cough, Dizziness, Dyspnoea
Clinical narrative: After receiving my third dose of the Pfizer vaccine (my booster shot) on Dec. 2, 2021, within 8 days, I was struggling with symptoms of racing heart rate, feeling lightheaded, dizzy, fatigue, and feeling winded when doing normal activity such as walking, stairs, cleaning, playing with my children. I have been struggling for almost 2 months now with ongoing symptoms and Tachycardia, especially upon standing. When I change position from sitting/resting to standing, my heart rate inexplicably sky rockets. This is prohibiting me from doing normal activities and has led to 2 ER visits and a ton of tests and expensive medical exams.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram, Electrocardiogram, Fatigue, Palpitations, Tachycardia
Clinical narrative: After receiving my third dose of the Pfizer vaccine (my booster shot) on Dec. 2, 2021, within 8 days, I was struggling with symptoms of racing heart rate, feeling lightheaded, dizzy, fatigue, and feeling winded when doing normal activity such as walking, stairs, cleaning, playing with my children. I have been struggling for almost 2 months now with ongoing symptoms and Tachycardia, especially upon standing. When I change position from sitting/resting to standing, my heart rate inexplicably sky rockets. This is prohibiting me from doing normal activities and has led to 2 ER visits and a ton of tests and expensive medical exams.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Myalgia, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: positive for covid.  congestion, sore throat, muscle aches.  Family all positive
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine stored in freezer for greater than 14 days
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID case.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, COVID-19, Cough, Death
Clinical narrative: Patient is fully vaccinated.  Patient presents to the ED secondary to known COVID - 19, reported symptoms for one week, tested +3 days ago. Patient states she is here due to cough, shortness of breath, and intractable diarrhea. Positive for myalgias, fatigue and weakness. Was given fluids. Also given dose of Rocephin here for urinary tract infection. Given Antivert for home use. Patient otherwise stable for discharge. Will return to the ER symptoms worsen. Pt did return 7 days later and was hospitalized.  EMS brought her to the hospital today due to altered mental status and hypoxemia. SPO2 was in the 50s and she was put on non-rebreather mask. Patient was altered and uncooperative at the ER, but she is now able to answer questions appropriately. Treatment:  Lovenox, IV antbiotics, decadron, remdesivir. Pt expired.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Hypoxia, Mental status changes
Clinical narrative: Patient is fully vaccinated.  Patient presents to the ED secondary to known COVID - 19, reported symptoms for one week, tested +3 days ago. Patient states she is here due to cough, shortness of breath, and intractable diarrhea. Positive for myalgias, fatigue and weakness. Was given fluids. Also given dose of Rocephin here for urinary tract infection. Given Antivert for home use. Patient otherwise stable for discharge. Will return to the ER symptoms worsen. Pt did return 7 days later and was hospitalized.  EMS brought her to the hospital today due to altered mental status and hypoxemia. SPO2 was in the 50s and she was put on non-rebreather mask. Patient was altered and uncooperative at the ER, but she is now able to answer questions appropriately. Treatment:  Lovenox, IV antbiotics, decadron, remdesivir. Pt expired.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Patient uncooperative, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Patient is fully vaccinated.  Patient presents to the ED secondary to known COVID - 19, reported symptoms for one week, tested +3 days ago. Patient states she is here due to cough, shortness of breath, and intractable diarrhea. Positive for myalgias, fatigue and weakness. Was given fluids. Also given dose of Rocephin here for urinary tract infection. Given Antivert for home use. Patient otherwise stable for discharge. Will return to the ER symptoms worsen. Pt did return 7 days later and was hospitalized.  EMS brought her to the hospital today due to altered mental status and hypoxemia. SPO2 was in the 50s and she was put on non-rebreather mask. Patient was altered and uncooperative at the ER, but she is now able to answer questions appropriately. Treatment:  Lovenox, IV antbiotics, decadron, remdesivir. Pt expired.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Headache, Fever, Nausea, and Pain in Arm lasting about 2 days.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Pt was given 0.2 ml of the Pediatric formulation which means that she was under-dosed by more than 50%.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Vision blurred
Clinical narrative: Blurred vision, dizzy, headache,,
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Malaise, SARS-CoV-2 test positive
Clinical narrative: He became ill  September 26, 2021. He was tested for COVID-19 with a positive result.  Passed away on October 12, 2021
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Mammogram, Ultrasound scan
Clinical narrative: I didn't have any allergic reaction to the vaccine but on 9/29 I had a mammogram performed it was discovered that the both axillary lymph nodes were was swollen.  With the left side being swollen a little more swollen than the right.   I have another Mammogram scheduled within the next 6months and we are just monitoring it to date.  An ultrasound of both breast was performed but all looks good
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine stored out-of-range (in freezer for greater than 14 days).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph nodes in armpit on affected side started swelling, as well as neck and now chest lymph nodes are swollen
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Patient states that shortly after being vaccinated with COVID19 vaccine, she developed an itchy feeling all over her body. She states that today the itching is now only to her hands.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Pt was given 0.2 ml of the pediatric formulation which mean she was under-dosed. She is being recalled to repeat the booster at the correct dosage.